Clorox Non-GAAP EPS of $1.55 beats by $0.48, revenue of $1.91B beats by $30M (CLX:NYSE)
Clorox reported Q1 Non-GAAP EPS of $1.55, exceeding estimates by $0.48. Revenue reached $1.91B, up 33.6% YoY, with organic sales increasing 18%. The GOJO acquisition contributed about 15 points to growth, according to the company.
How this was made
The 30-second read
Why it matters
The earnings beat provides a fresh catalyst for traders, especially in the pre‑market window.
Market read
The earnings surprise is likely to drive short‑term buying interest in CLX.
What to watch
Guidance outlook and margin trends were not disclosed, which could temper upside.
Background
Clorox released its Q1 2026 earnings, highlighting a strong rebound in sales and the contribution from the recent GOJO acquisition.
Ticker impact
Q1 Non-GAAP EPS of $1.55 beats expectations by $0.48 and revenue of $1.91B beats by $30M.
likely upside as the market prices in the earnings beat.
Both EPS and revenue exceeded expectations, providing a clear catalyst for buying pressure.
Market effects
Consumer staples may see modest lift from a major player beating expectations.
U.S. market sentiment could improve slightly in the consumer staples segment.
Limited to U.S. equities; no broader macro impact.
Counterpoint
If the beat is already priced in, the stock could face a short‑term pullback.
Key entities
- CompanyClorox Company
U.S. consumer‑goods firm reporting Q1 earnings.
